Showing 98,621 - 98,640 results of 133,910 for search '(( 2 we decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 2.15s Refine Results
  1. 98621

    DataSheet_1_Short-term effects of Chlorhexidine mouthwash and Listerine on oral microbiome in hospitalized patients.pdf by Tsunglin Liu (33873)

    Published 2023
    “…Before and after gargling the mouthwash twice a day for 5-7 days, oral bacteria were examined using a 16S rDNA approach.…”
  2. 98622

    Schematic illustrating the population-level response of the HIV and TB epidemics to a novel HIV control measure. by María S. Sánchez (367737)

    Published 2013
    “…<p>The relative growth rates of percent HIV prevalence (solid line) and TB incidence (dashed line) epidemics before and after the novel intervention (which for example could be the delivery of a new antiretroviral) are captured by in three different time intervals <i>i</i> = 1, 2 and 3. These intervals start before the novel intervention (with <i>t</i><sub>1</sub> representing the first year for which we have data), when the novel intervention is first implemented (at year <i>t</i><sub>2</sub>), and for the period starting at the point when TB incidence first decreases in scenario A (at year <i>t</i><sub>3</sub>). …”
  3. 98623

    Table_3_Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide.XLSX by Anna Gutowska (687799)

    Published 2022
    “…We administered Pom (0.2 mg/kg) orally to four HTLV-1-infected macaques over a 24 day period and collected blood, urine, and bone marrow samples throughout the study. …”
  4. 98624

    Table_1_Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide.XLSX by Anna Gutowska (687799)

    Published 2022
    “…We administered Pom (0.2 mg/kg) orally to four HTLV-1-infected macaques over a 24 day period and collected blood, urine, and bone marrow samples throughout the study. …”
  5. 98625

    Table_4_Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide.XLSX by Anna Gutowska (687799)

    Published 2022
    “…We administered Pom (0.2 mg/kg) orally to four HTLV-1-infected macaques over a 24 day period and collected blood, urine, and bone marrow samples throughout the study. …”
  6. 98626

    Table_7_Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide.xlsx by Anna Gutowska (687799)

    Published 2022
    “…We administered Pom (0.2 mg/kg) orally to four HTLV-1-infected macaques over a 24 day period and collected blood, urine, and bone marrow samples throughout the study. …”
  7. 98627

    Table_6_Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide.xlsx by Anna Gutowska (687799)

    Published 2022
    “…We administered Pom (0.2 mg/kg) orally to four HTLV-1-infected macaques over a 24 day period and collected blood, urine, and bone marrow samples throughout the study. …”
  8. 98628

    Image_1_Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide.PDF by Anna Gutowska (687799)

    Published 2022
    “…We administered Pom (0.2 mg/kg) orally to four HTLV-1-infected macaques over a 24 day period and collected blood, urine, and bone marrow samples throughout the study. …”
  9. 98629
  10. 98630
  11. 98631
  12. 98632
  13. 98633
  14. 98634
  15. 98635
  16. 98636
  17. 98637
  18. 98638
  19. 98639
  20. 98640